Navigation Links
JCSM: CPAP therapy improves symptoms of depression in OSA patients

WESTCHESTER, Ill. Patients with obstructive sleep apnea (OSA) who also suffer from depression often find that continued use of continuous positive airway pressure (CPAP) relieves them of symptoms of depression, according to a study published in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM).

Daniel J. Schwartz, MD, of The Sleep Center at Universitys Community Hospital in Tampa, Fla., surveyed patients referred to his sleep center for evaluation of OSA and who demonstrated a significant response to CPAP. The subjects were evaluated for symptoms of depression, were assessed again after four to six weeks of treatment with CPAP and then reassessed approximately one year later.

In this group of patients, the institution of CPAP therapy resulted in a significant decrease in those symptoms of depression that were assessed at both the short-term and long-term follow-up periods.

Why the use of CPAP is associated with the changes in these symptoms is incompletely understood. Whether relief of the obstructive respiratory events with CPAP might ameliorate the symptoms by improving sleep continuity, by ameliorating the adverse effects of various neurotransmitters, by alleviating the adverse effects of any attendant hypoxemia, or by a mechanism as yet unknown, cannot be determined on the basis of the findings of our study. But, the data from our study suggests that successful CPAP therapy is associated with a statistically significant improvement in symptoms of depression, and that the improvement is sustained long term, said Dr. Schwartz.

First introduced as a treatment option for sleep apnea in 1981, CPAP is the most common and effective treatment for OSA. CPAP provides a steady stream of pressurized air to patients through a mask that they wear during sleep. This airflow keeps the airway open, preventing the pauses in breathing that characterize sleep apnea and restoring normal oxygen levels.


Contact: Jim Arcuri
American Academy of Sleep Medicine

Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Acupuncture May Help Chemotherapy Side Effects
4. Antioxidants protect health tissue in people undergoing radiation therapy.
5. Distraction therapy found very effective in postoperative patients
6. Gene Therapy shows promise in treating Hemophilia
7. "Make AIDS Therapy affordable" - Physicians demand
8. Acupuncture superseeds massage therapy for short term relief of pain
9. Hormone replacement Therapy a headache
10. Simple Therapy
11. Ovarian cancer in relationship with Hormone therapy
Post Your Comments:
(Date:12/1/2015)... ... 01, 2015 , ... Tympani Inc., announced today that it ... Cisco. This designation recognizes Tympani as having fulfilled the training requirements and program ... the high-end enterprise contact center marketplace. , Ed Kapelinski, President of Tympani stated, ...
(Date:11/30/2015)... ... December 01, 2015 , ... The National Association of ... into its VIP Woman of the Year Circle. She is recognized with this ... exclusively for professional women, boasting 850,000 members and over 200 operating Local Chapters. ...
(Date:11/30/2015)... ... November 30, 2015 , ... Being a caregiver ... the VA Maryland Health Care System, the Caregiver Support Program promotes the health ... a difficult job. Seventy-four percent report that their role as a caregiver has ...
(Date:11/30/2015)... TX (PRWEB) , ... November 30, 2015 , ... ... plastic surgery and dermatology, is proud to announce that its ThermiRFR temperature controlled ... , ThermiRF is an innovative multi-application radiofrequency platform which uses temperature as a ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... and fun atmosphere for Halloween festivities, the Word of Life Christian Church of ... board game, and featuring a giant 1.25 ton pile of candy dubbed “Candy ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 /PRNewswire/ ... its wholly-owned UK subsidiary Proximagen Ltd., today announced a ... oral small molecule inhibitor of Vascular Adhesion Protein 1 ... the treatment of inflammatory disease. The VAP-1 inhibitor is ... --> --> Under the terms of ...
(Date:11/30/2015)... TOKYO , 1 décembre 2015 ... plus grande exposition et conférence d,Asie ... médicaux et sur l,industrie manufacturière, se ... du 20 au 22 avril ... - Photo - ...
(Date:11/30/2015)... 2015 --> ... - Pipeline Review, H2 2015" market research ... pipeline of Endometriosis and helps enhance decision ... to gain competitive advantage. It strengthens R&D ... to produce first-in-class and best-in-class products. ...
Breaking Medicine Technology: